SciCombinator

Discover the most talked about and latest scientific content & concepts.

Abstract
To determine the long-term safety and outcomes of mesenchymal stem cells (MSCs) for bronchopulmonary dysplasia in premature infants enrolled in a previous phase I clinical trial up to 2 years of corrected age (CA).
Tweets*
12
Facebook likes*
1
Reddit*
0
News coverage*
0
Blogs*
0
SC clicks
0
Concepts
Mesenchyme, Bronchopulmonary dysplasia, ClinicalTrials.gov, Clinical trial, Stem cells, Bone marrow, Stem cell, Mesenchymal stem cell
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com